rank,account_name,fit,urgency,total,fit_reason,urgency_reason,urgency_source,trigger_summary,best_fit_trial_title,best_fit_trial_status,best_fit_trial_phase,best_fit_trial_url,best_urgency_trial_title,best_urgency_trial_status,best_urgency_trial_phase,best_urgency_trial_url,sec_matched_total,patent_matched_total,target_roles
1,AstraZeneca,1.0,0.0,4.0,no trials,no trials and no relevant sec/patent signals,none,,,,,,,,,,0,0,"[""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development"", ""Clinical Scientist / Early Clinical Development Lead (Phase 1)""]"
2,GSK,1.0,0.0,4.0,no trials,no trials and no relevant sec/patent signals,none,,,,,,,,,,0,0,"[""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development"", ""Clinical Scientist / Early Clinical Development Lead (Phase 1)""]"
3,Pfizer,1.0,0.0,4.0,no trials,no trials and no relevant sec/patent signals,none,,,,,,,,,,0,0,"[""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development"", ""Clinical Scientist / Early Clinical Development Lead (Phase 1)""]"
